ClinicalTrials.Veeva

Menu
V

Vance Thompson Vision | Sioux Falls, SD

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

riboflavin
K-321
Timolol Maleate
Netarsudil
CBT-001
Ripasudil
MELT-300
QLS-101
Ketamine
Travoprost

Parent organization

This site is a part of Vance Thompson Vision

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 54 total trials

A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium

The objective is to evaluate the safety and efficacy of low dose and high dose CBT-001 eye drop dosed twice daily for 24 months compared to vehicle i...

Enrolling
Pterygium
Drug: CBT-001
Drug: Vehicle

The goal of this clinical trial is to learn if MELT-300 works on procedural sedation in adult participants undergoing cataract extraction with lens r...

Enrolling
Cataract
Drug: MELT-300 sublingual tablet
Drug: Placebo sublingual tablet

Prospective, multicenter, bilateral, interventional, controlled, masked (sponsor, subjects, and evaluators), randomized clinical trial.

Enrolling
Cataracts
Device: Test IOL Model DEN00V
Device: Control IOL Model DCB00

Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.

Enrolling
Myopia
Astigmatism
Device: WaveLight Wavefront Optimized
Procedure: Contoura with Phorcides

This study evaluates the duration of intraocular pressure (IOP)-lowering effect and safety of as needed administrations of Bimatoprost sustained rele...

Active, not recruiting
Open-Angle Glaucoma
Ocular Hypertension
Drug: Bimatoprost (SR)

To demonstrate the safety and effectiveness of TearCare® procedures compared to Restasis® to treat the signs and symptoms of dry eye disease in adult...

Active, not recruiting
Dry Eye
Meibomian Gland Dysfunction
Device: TearCare System
Drug: Restasis

Phase III study to compare the safety and efficacy of intraocular implants containing travoprost at two different elution rates versus Timolol Maleat...

Active, not recruiting
Ocular Hypertension
Glaucoma, Open-Angle
Combination Product: G2-TR intraocular implant containing travoprost
Drug: Sham surgery + active-comparator eye drops

Glaucoma is the second most common cause of blindness in the world, second only to cataracts. This study will assess how safe and effective a glaucom...

Enrolling
Open-Angle Glaucoma
Device: XEN45 (Glaucoma Gel Stent)

This study will be a 12-month, prospective, multicenter, open-label, non-comparative, non-randomized clinical investigation conducted at 8 to 14 site...

Enrolling
Refractive Error
Device: iDesign Refractive Studio with STAR S4 IR® Excimer laser System

Trial sponsors

V
Glaukos logo
A
Johnson & Johnson (J&J) logo
Abbott logo
AbbVie logo
Alcon logo
C
S
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems